The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #28568 · Form 4 · 0001493152-26-045366

Akari Therapeutics Plc · Stock award · American Depositary Shares representing Ordinary Shares

Akari Therapeutics Plc · Transacted September 29, 2026 · Filed October 1, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Akari Therapeutics Plc records a stock award involving American Depositary Shares representing Ordinary Shares on September 29, 2026. The reported quantity was 6,430. The filing date is October 1, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001541157
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
6,430
Reported price
9.72
Reference value
62,499.6
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
14,107
Ownership description
Not reported
SEC acceptance time
Oct 1, 2026, 4:50 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

AKTX · Nasdaq

This transaction is not mapped to a specific company listing.

Filing footnotes & remarks

F1
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. RSUs were granted on September 29, 2026 and vest in four approximately equal quarterly installments on November 18, 2026, February 18, 2027, May 18, 2027, and August 18, 2027, subject to continued service. The RSUs are subject to forfeiture and cancellation if the Issuer's shareholders do not approve an amendment to the Issuer's equity incentive plan increasing the number of shares reserved for issuance under the plan.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.